KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Assets: 2013-2025

Historic Return on Assets for Sarepta Therapeutics (SRPT) over the last 11 years, with Jun 2025 value amounting to -0.07%.

  • Sarepta Therapeutics' Return on Assets fell 8.00% to -0.07% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.07%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.07% for FY2024, which is 23.00% up from last year.
  • According to the latest figures from Q2 2025, Sarepta Therapeutics' Return on Assets is -0.07%, which was down 212.02% from 0.06% recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Return on Assets registered a high of 0.06% during Q4 2024, and its lowest value of -0.36% during Q1 2023.
  • In the last 3 years, Sarepta Therapeutics' Return on Assets had a median value of -0.07% in 2025 and averaged -0.11%.
  • Its Return on Assets has fluctuated over the past 5 years, first fell by 25bps in 2023, then surged by 37bps in 2024.
  • Sarepta Therapeutics' Return on Assets (Quarterly) stood at -0.14% in 2021, then declined by 8bps to -0.22% in 2022, then rose by 6bps to -0.17% in 2023, then increased by 23bps to 0.06% in 2024, then decreased by 8bps to -0.07% in 2025.
  • Its last three reported values are -0.07% in Q2 2025, 0.06% for Q4 2024, and 0.03% during Q3 2024.